GGrantIndex
← Search

EVALUATION OF THE SAFETY AND EFFICACY OF NE3107, A SAFE, ORALLY BIOAVAILABLE, BLOOD-BRAIN BARRIER-PERMEABLE ANTI-INFLAMMATORY AND INSULIN-SENSITIZING AGENT FOR TREATMENT OF LONG COVID

$499,200FY2025Defense Health AgencyDOD

Biovie Inc

Investigators

View source on USAspending →